Abstract
Abstract Financial conflicts of interest between pharmaceutical companies and medical experts appearing on television remain opaque. We revealed that seven (63.6%) of the 11 medical experts on non-satellite Japanese television programs covering COVID-19 received a combined $317,324 from 19 pharmaceutical companies in 2017. Further, only one of the experts published a single academic paper related to COVID-19. Also, over half the medical experts appearing on television were practicing clinicians and predominantly male.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
